GB

George Badescu

Chief Business Officer

Heidelberg Pharma AG

London, England


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Heidelberg Pharma AG
Industry
research
Employees
49.0
Seniority
C suite
Annual Revenue
6555000.0

Technologies

SendInBlue Mobile Friendly Joomla Apache Remote

Keywords

onkologie adc atac amanitin biotechnology research adc technology antibody-drug conjugates cancer therapy targeted therapy atac technology tumor resistance oncology clinical development bioconjugation biopharmaceuticals solid tumors hematological cancers innovative drugs drug development toxins drug delivery systems payloads cancer treatment therapeutic candidates bcma-atac cd37-atac psma-atac gcc-adc clinical trials fda approval orphan drug designation preclinical studies biomarkers rna polymerase ii apoptosis immuno-oncology therapeutic modalities drug candidates phase i trials phase ii trials molecular targets toxicology studies pharmacokinetics biological activity tumor microenvironment receptor-targeted therapy collaborative studies biotechnology partnerships drug efficacy serine protease inhibitors covid-19 treatment clinical efficacy preclinical trials pharmaceutical research hospital & health care health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans